OBJECTIVES: To evaluate the association between obesity and idiopathic intracranial hypertension (IIH) and establish whether there is a relationship with visual outcome. To calculate the prevalence and degree of obesity in a group of patients with IIH. METHODS: 34 patients (31 female and 3 male) were recruited between 1993 ± 1997 with a diagnosis of IIH. Assessment included visual acuity, visual ®eld assessment (Humphrey automated and Goldmann manual perimetry), fundus assessment and measurement of body mass index (BMI). Obesity was de®ned as a BMI of 30 kgam 2 . RESULTS: 70.5% of patients were obese. The relative risk for obesity and IIH was signi®cant at 8 (95%CI: 2,29). This increased to 17 (95%CI: 5,62) for obese females aged 16 to 24 years and 10 (95%CI: 3,35.5) for obese females aged 25 to 34 years. Morbid obesity (BMI b 40) was signi®cantly associated with poor visual outcome. Serial obesity measures showed generally little change in weight over time and there was no correlation between weight change and visual improvement. CONCLUSIONS: This study has documented a relationship between obesity and IIH. A high degree of obesity was associated with a poor visual function and identi®ed as a risk factor for poor outcome. Obesity may be an aetiological factor in this condition although it is unlikely to be the sole cause but more probably a precipitating factor. Weight loss is recommended although failure to lose weight is common. Any weight reduction programme must therefore be actively encouraged and monitored.
Introduction
The syndrome of idiopathic intracranial hypertension (IIH) is characterised by the symptoms and signs of raised intracranial pressure including headache, blurred vision, transient visual obscurations, papilloedema and sixth cranial nerve palsy. Loss of vision is the predominant morbid factor of this condition.
A number of studies and reviews have established risk factors for poor visual outcome in IIH. Systemic hypertension has been found to be a statistically signi®cant risk factor for poor visual outcome. 1 Another group which appear to be at risk for severe visual impairment are black males. 2 A prospective study by Wall and George 3 showed recent weight gain was signi®cantly associated with worsening vision. Risk factors which have been discredited include pregnancy, anaemia, older age and myopia.
The association of obesity with IIH has been reported in many studies.
1,4 ± 6 The aim of this study has been to evaluate the association of obesity with IIH in a well de®ned population with a known incidence of obesity, and establish whether there is a relationship with weight change and visual outcome. The prevalence and degree of obesity have been calculated in a group of patients with IIH.
Methods and materials
In the absence of pathological criteria for IIH, clear clinical criteria (by which the condition may be de®ned for study) are essential. In recent studies, the modi®ed Dandy criteria have been most commonly used 7 ± 10 and were also used for the recruitment of patients to this study. These relate the signs and symptoms of raised intracranial pressure in an otherwise healthy patient with no other evidence of pathology relating to the intracranial hypertension. The criteria are outlined in Figure 1 . Exclusion criteria included non-ful®lment of diagnostic criteria, diagnosis prior to 1993, less than six months followup and those patients with intracranial hypertension due to venous sinus thrombosis.
This prospective study recruited 34 consecutive new patients to the Department of Ophthalmology at Addenbrooke's Hospital (a district and tertiary referral centre) between 1993 ± 1997. Patients were followed over an average time period of two years (six months to four years). The female:male ratio was 10:1 and the mean age was 28 y (range 11 ± 57 y).
Visual ®eld assessments were performed with the Humphrey automated and Goldmann manual perimeters. A grading system was used to classify visual ®eld defects documented with Humphrey and Goldmann perimetry 3 ( Figure 2 and Figure 3 ). Grade 0 represented a normal ®eld and grades 1 ± 5 indicated visual ®eld de®cits of increasing severity with grade 5 representing blinding visual loss. The Humphrey 24-2 full threshold test programme was used, which tests the central 24 degrees of the visual ®eld and tests 54 points with a six degree spaced grid offset from the vertical and horizontal meridians. Goldmann perimetry involved kinetic documentation of the peripheral and central visual ®eld isopters and also static perimetry, using a modi®ed Armaly-Drance testing strategy, to assess the central 30 degrees and the nasal horizontal meridian. Visual outcome was classed as excellent with normal visual ®elds, good with minimal or mild visual ®eld de®cit (grades 1 ± 2), satisfactory with moderate visual ®eld de®cit (grade 3) or poor with marked or blinding visual loss (grades 4 ± 5).
The level of obesity was determined by body mass index (BMI) which is weight (kg) divided by the square of height (m). Overweight was de®ned as a BMI of 26 kgam 2 and obesity as a BMI of 30 kgam 2 . Thus, those classi®ed as`overweight' also include those called`obese'.
In order to calculate relative risk of obesity and IIH, it was necessary to obtain the population data for the region. A de®ned population is required for the calculation of risk and prevalence, and the population data was determined for the referral area of Addenbrooke's Hospital. The medical care of the residents of Cambridge is provided almost entirely by Addenbrooke's Hospital. Those patients with private health insurance would be referred for private consultation. However, combined private Orthoptic and visual ®eld assessment for these patients would be provided at Addenbrooke's Hospital. Residency was established in Cambridge for at least one year prior to the onset of symptoms. In this way, the risk of not including patients who might have been referred to other hospitals in the East Anglian region would be avoided. The 34 patients in this study were all resident in the East Anglian region. Ten patients were resident in the Addenbrooke's Hospital referral area.
The population census records from 1991 for East Anglia were obtained from the national register (Of®ce for National Statistics) and included an overall population count and breakdown into male and female populations. A further breakdown by age was obtained (Table 1) . Detailed census records are Association of obesity with IIH FJ Rowe and NJ Sarkies collated each decade and the 1991 census provided the last detailed population data. Detailed population data for the study period were not available. However, the increase in population from 1991 ± 1996 was 3.1%, with a projected annual increase in population of 0.6%. A factor for this projected increase in population was built into the calculations for this study.
Epidemiological data were provided by the Dunn Nutrition Unit, Cambridge, from a national survey on obesity 12 and its incidence by region and in the overall UK population. These obesity ®gures related to the time period of this study and provided a breakdown into male and female populations, and a further breakdown by age. There was an incidence of 53% overweight and 16% obesity in the adult population for East Anglia, according to this study. For females aged 16 ± 24 y, the incidence of overweight was 28% and obesity, 8%. For females aged 25 ± 34 y, the incidence for overweight was 38% and 13% for obesity.
Treatment of IIH was varied due to the individual responses to both medical and surgical treatment. Six patients had no treatment and for the remaining 28, treatment included either medical (acetazolamide, bendro¯uazide), serial lumbar punctures or surgical (CSF shunts, optic nerve sheath fenestration) intervention or a combination.
A standard lumbar puncture technique was used to take CSF pressure measurements. The patient was placed in a supine position and a 1.5 mm by 150 cm tube was used to measure CSF pressure. The range of CSF pressures at ®rst assessment was 260 ± 790 mm H 2 O. All CSF measurements were repeated at subsequent visits and consistently elevated measurements were obtained either by lumbar puncture or intracranial pressure monitoring techniques.
The SPSS statistical programme was used for statistical analysis and the following tests used: correlation (Spearman rank correlation coef®cients), Kendall's analysis of concordance, comparison of paired and independent means (t test), non parametric analysis (Chi squared test and Wilcoxon test). Relative risk factors were determined with the calculation:
where a and b represent the proportion of overweightaobesity and normal weight in the IIH population and c and d represent the proportion of overweightaobesity and normal weight in the general population. 95% con®dence intervals (95% CI) were determined with the calculation:
Results
At the initial and ®nal visit, 32 patients (94%) were overweight and two had normal weight for height. The 32 overweight patients included 24 obese patients (70.5%) with a BMI ! kgam 2 , nine of whom had a BMI ! 40 kgam 2 . In order to compare the prevalence of obesity with IIH, the ratio of these two factors was calculated as a measure of the raised risk in one group compared to the other. Under the null hypothesis, the expected value of the relative risk is 1. The relative risk for the prevalence of overweight and obesity with IIH in the Addenbrooke's Hospital referral area was signi®cant. The relative risk of overweight with IIH was 8 (95% CI: 1 and 62); of obesity with IIH was 8 (95% CI: 2 and 29). The relative risk was also calculated for adult females in the age groups of 16 ± 24 y and 25 ± 34 y. The relative risk of overweight with IIH was 23 (95% CI: 3 and 180) for females aged 16 ± 24 y and 15 (95% CI: 2 and 118) for females aged 25 ± 34 y. The relative risk of obesity with IIH was 17 (95% CI: 5 and 62) for females aged 16 ± 24 y and 10 (95% CI: 3 and 35.5) for females aged 25 ± 34 y.
Serial measurements of obesity were analysed for change over time and from ®rst to last visit (Figure 4 ). There was no signi®cant change over time (P 0.9488, Kendal coef®cient of concordance) or from ®rst to last visit (P 0.7557, Wilcoxon test, Table 2 ). Eleven patients (32%) remained at the same weight, 14 (41%) lost an average of 3.5 kg (1 ± 17 kg) and nine (27%) gained an average of 6 kg (1 ± 15 kg). Seven patients had a history of recent weight gain, three prior to initial presentation and four prior to a recurrence of symptoms during follow up. The average weight gain was 16.5 kg (5 ± 25 kg). These patients did not, however, have a poorer visual outcome (P 0.6, independent t test).
Visual function as assessed by visual ®elds showed a general trend of improvement over time (P 0.1458, Kendal coef®cient of concordance) and was signi®cantly improved from ®rst to last visit (P 0.0013, Wilcoxon test Figure 5 ). Intracranial pressure also showed a general trend of improvement over time (P 0.2407, Kendal coef®cient of Association of obesity with IIH FJ Rowe and NJ Sarkies concordance) and was signi®cantly improved from ®rst to last visit (P 0.0004, Wilcoxon test). There was no signi®cant correlation between change in weight and improvement of visual function or intracranial pressure (P 0.238 and P 0.616, respectively, Chi squared test). In those patients who gained weight (n 9), there was no signi®cant deterioration in visual outcome (P 0.394, independent t test). In those patients who lost weight (n 14), there was no signi®cant improvement in visual outcome (P 0.629, independent t test). The average weight loss was 3.5 kg (1 ± 17 kg) and only two patients lost b 5% of their body weight (6.5% and 18%, respectively). The degree of obesity (level of BMI) was compared to the eventual visual outcome at ®nal visit. Patients with a BMI`30 kgam 2 were more likely to have a better visual outcome (mean 0.7 visual ®eld grade) than obese patients with a BMI ! 30 kgam 2 (mean 1.4 visual ®eld grade) although this was not statistically signi®cant (P 0.092, independent t test). However, a BMI ! 40 kgam 2 was signi®cantly associated with poor visual outcome (P 0.047, independent t test). The degree of obesity was also correlated with persisting symptoms and recurrence of the condition during the follow up period, and was not found to be of signi®cance (P 0.742 and P 0.274, respectively, Spearman correlation coef®cients, P 0.861 and P 0.674, respectively, independent t test).
Discussion

Obesity and IIH
Obesity has long been associated with IIH and the typical patient with IIH has been described as a young obese female. 5 The incidence of IIH has been calculated at 0.9 ± 2.23 per 100 000 persons for the total population, 3.5 ± 12 per 100 000 females in the age group of 15 ± 44 y and an incidence of 0.3 per 100 000 males in the same age group. 4,9,10 Durcan et al 4 described an increase in incidence to 13 per 100 000 for females who were 10% over their ideal weight and an increase to 19.3 per 100 000 for females 20% over their ideal weight. Radhakrishnan et al 10 calculated an increase in incidence to 21.4 per 100 000 for obese females with a BMI ! 30 kgam 2 . Figure 5 Improvement of visual ®elds from initial to ®nal assessment.
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In this study, 94% of patients were overweight (which included 70.5% obese patients). The relative risk of obesity and IIH was calculated using referral area population and obesity data, and was found to be signi®cantly greater for overweight (relative risk 8, 95% CI: 1,62) and obese adults (relative risk 8, 95% CI: 2,29), than for the nonobese patients. Patients were predominantly female and the relative risk was therefore also calculated for overweight and obese female adults, in which the risk factors rose, particularly in the age groups of 16 ± 24 y (overweight relative risk 23, 95% CI: 3,180 and obese relative risk 17, 95% CI: 5,62).
Ireland et al 13 have reported a signi®cant weight gain in IIH patients during the six months preceding diagnosis, and their study con®rmed a strong association between IIH, obesity and weight gain during the 12 months before diagnosis. Wall and George 3 showed recent weight gain as the only signi®cant factor associated with reduced vision in their patients. Most of their patients had improved vision at the ®nal visit. However, ®ve patients had worsening visual function, with recent weight gain as the associated risk factor. In this study, patients with recent weight gain did not have a signi®cant association with poor visual function. In general, a good visual outcome was achieved by the ®nal visit. However a high degree of obesity was found to be signi®cantly associated with those patients with poor visual outcome. A BMI ! 40 kgam 2 was identi®ed as a risk factor for patients with poor visual outcome.
Reid and Thompson 14 stated that patients with persisting symptoms were strikingly obese compared with those whose symptoms had resolved. Weisberg 15 found that of those patients whose symptoms resolved within three months, only 33% were obese. By contrast, 90% of patients whose symptoms persisted for at least 12 months were obese. There was no similar correlation between obesity and persisting symptoms in the present study.
Pathophysiology
The pathophysiological relationship between obesity and IIH is unknown. Obesity may, however, be an important aetiological factor in IIH and a number of possible explanations have been postulated for this. The three main factors implicated in the aetiology of IIH are cerebral oedema, an abnormality in CSF absorption and an increase in cerebral blood volume. These factors may occur independently or coexist.
Obesity has been proposed to be associated with cerebral oedema 16 where neuroendocrine disturbances may lead to increased brain water content. 17 Extraovarian production of estrone may link obesity to IIH. Androstenedione is converted exclusively to estrone by adipocytes 18 and can be stored in fat. The percentage of androstenedione converted to estrone has been documented as increasing with age and with obesity. In young women, the conversion of androstenedione to estrone increases exponentially when body weight exceeds 50% over ideal body weight. 19 The increased estrone levels with obesity, which may not be suf®-cient to give abnormal results on endocrine testing, may result in a relative hypoadrenalism of a level to alter the drainage channels and vacuolar transport across the arachnoid villi and increase resistance to CSF out¯ow.
High intraabdominal pressures have been implicated in association with obesity and the aetiology of IIH. Morbidly obese patients have signi®cantly higher intraabdominal pressures than nonobese patients, and have a higher incidence of IIH. 20 These authors evaluated the relationship between increased intraabdominal pressures, intracranial pressure and cerebral perfusion pressure 21 and in a later study 20 suggested that increased intraabdominal pressure produced raised intracranial pressure by raising the diaphragm and increasing intrathoracic pressure, thereby reducing cerebral venous return to the heart via the jugular vein system. This in turn would obstruct cerebral venous out¯ow, raise cerebral blood volume and increase intracranial pressure by preventing normal cerebrospinal¯uid absorption.
The prevalence of obesity in the East Anglian population has been reported as 16%. 12 IIH is strongly associated with obesity. However, if obesity was the sole aetiological factor in IIH, the incidence of IIH would also be expected to re¯ect that of obesity in the population. This is not the case, as IIH remains an uncommon condition. There must therefore be an additional aetiological factor, for example, an underlying anatomical abnormality of the arachnoid villi thereby rendering the drainage mechanism for CSF susceptible to other precipitating factors.
Weight loss
Weight loss should be recommended for every obese patient with IIH who is not pregnant. However, failure to lose weight is common, 6 as was the case in this study.
In this study, 14 patients (41%) lost weight, but none to within the normal weight for height range. Nine patients (27%) had a gain in weight and the remaining 11 patients (32%) remained at the same weight. There was no signi®cant change in weight over time. Those patients who gained weight did not have any signi®cant deterioration in their visual function or increase in ICP. Those who lost weight also did not experience any signi®cant improvement in visual function or decrease in ICP.
A number of studies have addressed the successful treatment of obesity in patients with IIH. Methods of weight loss have included rice diet 22 and gastric exclusion procedure. 23 ± 25 The success of these studies may, however, relate to the extent of weight loss. The average weight loss in the present study was 3.5 kg (1 ± 17 kg), in comparison to signi®cant weight losses of 34 kg (11 ± 56 kg) with a low calorie Association of obesity with IIH FJ Rowe and NJ Sarkies adaptation of a rice diet with salt exclusion, 22 and 47 kg (41 ± 73 kg) with gastric exclusion surgery. 25 Whilst therapies that promote weight loss may be appropriate management strategies for this condition, signi®cant weight loss appears to be required for this to become an effective treatment.
